paroxetine has been researched along with Abnormality, Heart in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 12 (48.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC | 1 |
Blackwell, KA; Forray, A; Glover, J; Yonkers, KA | 1 |
Aydin, B; Beken, S; Dilli, D; Dinlen, N; Okumuş, N; Zenciroğlu, A | 1 |
Bérard, A; Boukhris, T; Chaabane, S; Iessa, N; Muanda, FT; Zhao, JP | 1 |
Bérard, A; Boukhris, T; Chaabane, S; Muanda, FT; Zhao, J | 1 |
Avgil, M; Clementi, M; Di Gianantonio, E; Diav-Citrin, O; Ornoy, A; Schaefer, C; Shechtman, S; Wajnberg, R; Weber-Schoendorfer, C; Weinbaum, D | 1 |
Einarson, A; Einarson, TR; Koren, G; O'Brien, L; Sarkar, M | 1 |
Jureidini, J; Mintzes, B | 1 |
Ephross, SA; Olshan, AF; Poole, C; Wurst, KE | 1 |
Tanne, JH | 2 |
Bérard, A | 1 |
Scialli, AR | 1 |
Einarson, A; Koren, G | 2 |
Einarson, A | 2 |
Aoun, J; Gorsane, MA; Krebs, MO; Soufia, M | 1 |
Bérard, A; Crespin, S; Damase-Michel, C; Sheehy, O | 1 |
Källén, B; Otterblad Olausson, P | 1 |
Cuzzell, JZ | 1 |
Hallberg, P; Odlind, V; Sjöblom, V | 1 |
Bérard, A; Blais, L; Oraichi, D; Ramos, E; Rey, E; St-André, M | 1 |
DeSantis, M; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Paulus, WD; Pistelli, A | 1 |
7 review(s) available for paroxetine and Abnormality, Heart
Article | Year |
---|---|
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
Antidepressant use in pregnant and postpartum women.
Topics: Antidepressive Agents; Depression, Postpartum; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2014 |
The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
Topics: Abnormalities, Drug-Induced; Female; Heart Defects, Congenital; Humans; Maternal Exposure; Paroxetine; Pregnancy; Pregnancy Trimester, First; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2016 |
Does paroxetine cause cardiac malformations?
Topics: Case-Control Studies; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors | 2008 |
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors | 2010 |
[SSRIs and pregnancy: a review of the literature].
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Infant, Newborn, Diseases; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk Assessment; Selective Serotonin Reuptake Inhibitors | 2010 |
Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Bias; Causality; Compensation and Redress; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Drug Utilization; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Publishing; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2012 |
18 other study(ies) available for paroxetine and Abnormality, Heart
Article | Year |
---|---|
Treacher Collins syndrome with multiple congenital heart defects after paroxetine exposure: case report.
Topics: Abnormalities, Multiple; Adult; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Mandibulofacial Dysostosis; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors | 2014 |
Paroxetine use during pregnancy and the risk of cardiac defects.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors | 2016 |
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Antidepressive Agents, Second-Generation; Birth Weight; Case-Control Studies; Confidence Intervals; Drug Administration Schedule; Female; Fluoxetine; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Maternal Age; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors | 2008 |
Should paroxetine be used to treat depression during pregnancy?
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome | 2008 |
GSK is sued in US over alleged link of paroxetine to birth defects.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Drug Industry; Heart Defects, Congenital; Humans; Infant; Male; Paroxetine; Teratogens; United States | 2009 |
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.
Topics: Antidepressive Agents, Second-Generation; Child, Preschool; Compensation and Redress; Depressive Disorder; Drug Industry; Female; Heart Defects, Congenital; Humans; Male; Paroxetine; Philadelphia; Pregnancy; Pregnancy Complications | 2009 |
Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?
Topics: Abnormalities, Drug-Induced; Adult; Data Interpretation, Statistical; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty | 2010 |
Paroxetine exposure during pregnancy and cardiac malformations.
Topics: Abnormalities, Drug-Induced; Animals; Data Interpretation, Statistical; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Mice; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Trimester, First; Rabbits; Rats; Selective Serotonin Reuptake Inhibitors; Species Specificity; Uncertainty | 2010 |
First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors | 2010 |
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
Topics: Abnormalities, Drug-Induced; Adult; Depression; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty | 2010 |
Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; France; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prevalence; Quebec | 2012 |
Antidepressant drugs during pregnancy and infant congenital heart defect.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Clomipramine; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Sweden | 2006 |
Paroxetine may increase risk for congenital malformations.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Female; Heart Defects, Congenital; Humans; Paroxetine; Pregnancy; Pregnancy Trimester, First; Teratogens | 2006 |
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Topics: Abnormalities, Drug-Induced; Confounding Factors, Epidemiologic; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Mental Disorders; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors | 2006 |
Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
Topics: Canada; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Paroxetine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors | 2006 |
SSRI antidepressants and birth defects.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Denmark; Depression; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Sweden; Teratogens; United States | 2006 |
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Middle Aged; Paroxetine; Pregnancy; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors | 2007 |
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Risk Assessment | 2008 |